Carisma Therapeutics to Participate in the Jefferies Global Healthcare Conference

Rhea-AI Summary

Carisma Therapeutics (Nasdaq: CARM), a clinical-stage biopharmaceutical company, announced its participation in the Jefferies Global Healthcare Conference. Steven Kelly, President and CEO, will join a fireside chat on June 6, 2024, at 3:00 pm ET. An audio webcast will be available on the Investor Events section of the company's website and archived for a time.

Positive

• Participation in a prestigious event like the Jefferies Global Healthcare Conference can enhance Carisma Therapeutics' visibility among investors and stakeholders.
• The involvement of Steven Kelly, the CEO, in the fireside chat may provide valuable insights into the company's future plans and strategic direction.

Negative

• The press release does not provide specific updates on the company's financial performance, clinical trial progress, or any new business developments, limiting the information for investors seeking detailed updates.
• The announcement of an audio webcast being archived for a time may not be sufficient for all investors, particularly those who may miss the live event or the archive window.

PHILADELPHIA, May 30, 2024 /PRNewswire/ -- Carisma Therapeutics Inc. (Nasdaq: CARM) ("Carisma" or the "Company"), a clinical-stage biopharmaceutical company focused on discovering and developing innovative immunotherapies, today announced that Steven Kelly, President and Chief Executive Officer, will participate in a fireside chat at the Jefferies Global Healthcare Conference on Thursday, June 6^th at 3:00 pm ET.

An audio webcast of the event will be available on the Company's Investor Events section of the Investor Relations webpage and will be archived for a limited time following the event.

About Carisma

Carisma Therapeutics Inc. is a clinical-stage biopharmaceutical company focused on utilizing our proprietary macrophage and monocyte cell engineering platform to develop transformative immunotherapies to treat cancer and other serious diseases. We have created a comprehensive, differentiated proprietary cell therapy platform focused on engineered macrophages and monocytes, cells that play a crucial role in both the innate and adaptive immune response. Carisma is headquartered in Philadelphia, PA. For more information, please visit www.carismatx.com.

Investors:
Shveta Dighe
Head of Investor Relations
investors@carismatx.com

Media Contact:
Julia Stern
(763) 350-5223
jstern@realchemistry.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/carisma-therapeutics-to-participate-in-the-jefferies-global-healthcare-conference-302158376.html

SOURCE Carisma Therapeutics Inc.

FAQ

When will Carisma Therapeutics participate in the Jefferies Global Healthcare Conference?

Carisma Therapeutics will participate in the Jefferies Global Healthcare Conference on June 6, 2024, at 3:00 pm ET.

Who will represent Carisma Therapeutics at the Jefferies Global Healthcare Conference?

Steven Kelly, President and CEO of Carisma Therapeutics, will represent the company at the conference.

Where can I access the audio webcast of Carisma Therapeutics' presentation at the Jefferies Global Healthcare Conference?

The audio webcast will be available on the Investor Events section of Carisma Therapeutics' Investor Relations webpage.

Will the audio webcast of Carisma Therapeutics' presentation be archived?

Yes, the audio webcast will be archived for a time following the event.